These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21932445

  • 1. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
    Dai L, He J, Liu Y, Byun J, Vivekanandan A, Pennathur S, Fan X, Lubman DM.
    Proteomics; 2011 Dec; 11(23):4529-40. PubMed ID: 21932445
    [Abstract] [Full Text] [Related]

  • 2. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.
    Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
    Dai L, Liu Y, He J, Flack CG, Talsma CE, Crowley JG, Muraszko KM, Fan X, Lubman DM.
    Proteomics; 2011 Oct; 11(20):4021-8. PubMed ID: 21898824
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD, Jeevan DS, Tobias M, Murali R, Jhanwar-Uniyal M.
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [Abstract] [Full Text] [Related]

  • 8. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K, Nedergaard MK, Villingshøj M, Borup R, Broholm H, Kjær A, Poulsen HS, Stockhausen MT.
    Cancer Biol Ther; 2014 Jul 21; 15(7):862-77. PubMed ID: 24755988
    [Abstract] [Full Text] [Related]

  • 11. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
    Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT.
    Cancer Biol Ther; 2013 Jul 21; 14(7):625-37. PubMed ID: 23792644
    [Abstract] [Full Text] [Related]

  • 12. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
    Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A.
    Molecules; 2021 Feb 12; 26(4):. PubMed ID: 33673088
    [Abstract] [Full Text] [Related]

  • 13. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E, Lang V, Bohlen J, Bethke F, Puccio L, Tichy D, Herold-Mende C, Hielscher T, Lichter P, Goidts V.
    Int J Cancer; 2016 Oct 15; 139(8):1776-87. PubMed ID: 27299852
    [Abstract] [Full Text] [Related]

  • 14. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.
    Gilbert CA, Daou MC, Moser RP, Ross AH.
    Cancer Res; 2010 Sep 01; 70(17):6870-9. PubMed ID: 20736377
    [Abstract] [Full Text] [Related]

  • 15. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S, Zappelli E, Natali L, Martini C, Trincavelli ML.
    Cell Death Dis; 2014 Nov 27; 5(11):e1539. PubMed ID: 25429616
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-β mimics the key proteome properties of CD133- differentiated and CD133+ cancer stem cells in glioblastoma.
    Bryukhovetskiy I, Shevchenko V, Arnotskaya N, Kushnir T, Pak O, Victor Z, Zaitsev S, Khotimchenko Y, Bryukhovetskiy A, Sharma A, Sharma HS.
    Int Rev Neurobiol; 2020 Nov 27; 151():219-242. PubMed ID: 32448609
    [Abstract] [Full Text] [Related]

  • 17. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V, Arnotskaya N, Korneyko M, Zaytsev S, Khotimchenko Y, Sharma H, Bryukhovetskiy I.
    Oncol Rep; 2019 May 27; 41(5):3080-3088. PubMed ID: 30864699
    [Abstract] [Full Text] [Related]

  • 18. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS.
    Neoplasia; 2015 Jun 27; 17(6):497-508. PubMed ID: 26152358
    [Abstract] [Full Text] [Related]

  • 19. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW, Kim SJ, Choi IJ, Song J, Chun KH.
    Clin Exp Metastasis; 2015 Aug 27; 32(6):593-603. PubMed ID: 26134677
    [Abstract] [Full Text] [Related]

  • 20. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
    Carra E, Barbieri F, Marubbi D, Pattarozzi A, Favoni RE, Florio T, Daga A.
    Cell Cycle; 2013 Feb 01; 12(3):491-500. PubMed ID: 23324350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.